Invesco Ltd. Adaptive Biotechnologies Corp Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Invesco Ltd. holds 168,606 shares of ADPT stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

168,606

Previous 171,860 1.89%

Holding current value

$1.32 Million

Previous $622,000 38.75%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$3.37 - $5.12 $10,965 - $16,660	-3,254 Reduced 1.89%	168,606 $863,000
Q2 2024 Aug 13, 2024	SELL	$2.34 - $3.96 $6,308 - $10,676	-2,696 Reduced 1.54%	171,860 $622,000
Q1 2024 May 14, 2024	BUY	$2.88 - $4.8 $190,123 - $316,872	66,015 Added 60.82%	174,556 $560,000
Q4 2023 Feb 12, 2024	BUY	$3.46 - $5.33 $4,203 - $6,475	1,215 Added 1.13%	108,541 $531,000
Q3 2023 Nov 13, 2023	SELL	$5.07 - $8.44 $14,500 - $24,138	-2,860 Reduced 2.6%	107,326 $584,000
Q2 2023 Aug 11, 2023	BUY	$6.19 - $8.78 $23,367 - $33,144	3,775 Added 3.55%	110,186 $739,000
Q1 2023 May 12, 2023	BUY	$7.8 - $10.11 $96,064 - $124,514	12,316 Added 13.09%	106,411 $939,000
Q4 2022 Feb 13, 2023	BUY	$6.26 - $9.34 $14,898 - $22,229	2,380 Added 2.59%	94,095 $718,000
Q3 2022 Nov 14, 2022	SELL	$6.5 - $12.67 $18,070 - $35,222	-2,780 Reduced 2.94%	91,715 $653,000
Q2 2022 Aug 15, 2022	SELL	$6.4 - $14.73 $328,352 - $755,722	-51,305 Reduced 35.19%	94,495 $764,000
Q1 2022 May 16, 2022	SELL	$10.12 - $28.9 $14.2 Million - $40.6 Million	-1,403,282 Reduced 90.59%	145,800 $2.02 Million
Q4 2021 Feb 14, 2022	BUY	$25.17 - $36.85 $919,661 - $1.35 Million	36,538 Added 2.42%	1,549,082 $43.5 Million
Q3 2021 Nov 15, 2021	SELL	$30.02 - $39.87 $603,101 - $800,988	-20,090 Reduced 1.31%	1,512,544 $51.4 Million
Q2 2021 Aug 17, 2021	BUY	$32.22 - $44.59 $6.87 Million - $9.51 Million	213,167 Added 16.16%	1,532,634 $62.6 Million
Q1 2021 May 17, 2021	SELL	$37.26 - $67.74 $7.64 Million - $13.9 Million	-204,963 Reduced 13.45%	1,319,467 $53.1 Million
Q4 2020 Feb 16, 2021	BUY	$45.01 - $65.47 $11.5 Million - $16.7 Million	254,801 Added 20.07%	1,524,430 $90.1 Million
Q3 2020 Nov 16, 2020	BUY	$35.79 - $48.81 $1.39 Million - $1.89 Million	38,792 Added 3.15%	1,269,629 $61.7 Million
Q2 2020 Aug 14, 2020	BUY	$24.95 - $48.38 $25.1 Million - $48.7 Million	1,006,018 Added 447.48%	1,230,837 $59.5 Million
Q1 2020 May 15, 2020	SELL	$16.96 - $34.16 $518,111 - $1.04 Million	-30,549 Reduced 11.96%	224,819 $6.25 Million
Q4 2019 Feb 14, 2020	BUY	$24.56 - $32.8 $629,079 - $840,139	25,614 Added 11.15%	255,368 $7.64 Million
Q3 2019 Nov 14, 2019	BUY	$30.31 - $53.51 $144,093 - $254,386	4,754 Added 2.11%	229,754 $7.1 Million
Q2 2019 Aug 14, 2019	BUY	$40.3 - $48.3 $9.07 Million - $10.9 Million	225,000 New	225,000 $10.9 Million

Others Institutions Holding ADPT

# of Institutions

206

Shares Held

142M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $1.12B
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account